MEDP - Medpace Holdings, Inc.

298.18
-0.370   -0.124%

Share volume: 390,351
Last Updated: 04-28-2025
Business Services/Services – Research, Development, Testing Labs: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$298.55
-0.37
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
50%
Profitability 64%
Dept financing 13%
Liquidity 9%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.76%
1 Month
-4.42%
3 Months
-13.67%
6 Months
-9.35%
1 Year
-25.40%
2 Year
49.17%
Key data
Stock price
$298.18
P/E Ratio 
22.29
DAY RANGE
$294.53 - $303.30
EPS 
$13.51
52 WEEK RANGE
$250.05 - $459.77
52 WEEK CHANGE
-$25.40
MARKET CAP 
9.283 B
YIELD 
N/A
SHARES OUTSTANDING 
28.742 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.38
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,091,387
AVERAGE 30 VOLUME 
$785,535
Company detail
CEO: August J. Troendle
Region: US
Website: medpace.com
Employees: 5,200
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.

Recent news
loading